Fleur Gaudette

506 total citations
29 papers, 336 citations indexed

About

Fleur Gaudette is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Fleur Gaudette has authored 29 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cellular and Molecular Neuroscience, 9 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Fleur Gaudette's work include Neuroscience and Neuropharmacology Research (11 papers), Receptor Mechanisms and Signaling (7 papers) and Analytical Chemistry and Chromatography (5 papers). Fleur Gaudette is often cited by papers focused on Neuroscience and Neuropharmacology Research (11 papers), Receptor Mechanisms and Signaling (7 papers) and Analytical Chemistry and Chromatography (5 papers). Fleur Gaudette collaborates with scholars based in Canada, United States and France. Fleur Gaudette's co-authors include Francis Beaudry, Véronique Michaud, Dominique Bédard, Philippe Huot, Jacques Turgeon, Adjia Hamadjida, Stephen G. Nuara, Jim C. Gourdon, Cynthia Kwan and Imane Frouni and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Pharmacology and Experimental Therapeutics and Experimental Brain Research.

In The Last Decade

Fleur Gaudette

27 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fleur Gaudette Canada 13 160 80 74 72 38 29 336
Klaus Klinder Germany 13 89 0.6× 61 0.8× 50 0.7× 143 2.0× 50 1.3× 15 419
Laura Iavarone Italy 11 113 0.7× 28 0.3× 51 0.7× 193 2.7× 29 0.8× 25 417
S. Aubrey Stoch United States 12 90 0.6× 26 0.3× 35 0.5× 102 1.4× 53 1.4× 26 383
Monique Schmitt Switzerland 11 59 0.4× 182 2.3× 113 1.5× 109 1.5× 83 2.2× 23 607
Vikash Sinha United States 9 82 0.5× 18 0.2× 24 0.3× 108 1.5× 81 2.1× 18 330
Leonel Torrão Portugal 10 53 0.3× 138 1.7× 30 0.4× 103 1.4× 21 0.6× 17 377
Anna Furgała Poland 12 76 0.5× 36 0.5× 44 0.6× 84 1.2× 79 2.1× 23 377
S.-�. Eckern�s Sweden 8 58 0.4× 50 0.6× 24 0.3× 73 1.0× 28 0.7× 9 328
Philipp Huguenin Switzerland 8 74 0.5× 18 0.2× 72 1.0× 111 1.5× 42 1.1× 17 510
Terese Seifert United States 10 89 0.6× 12 0.1× 39 0.5× 120 1.7× 37 1.0× 13 421

Countries citing papers authored by Fleur Gaudette

Since Specialization
Citations

This map shows the geographic impact of Fleur Gaudette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fleur Gaudette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fleur Gaudette more than expected).

Fields of papers citing papers by Fleur Gaudette

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fleur Gaudette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fleur Gaudette. The network helps show where Fleur Gaudette may publish in the future.

Co-authorship network of co-authors of Fleur Gaudette

This figure shows the co-authorship network connecting the top 25 collaborators of Fleur Gaudette. A scholar is included among the top collaborators of Fleur Gaudette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fleur Gaudette. Fleur Gaudette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gaudette, Fleur, Cynthia Kwan, Adjia Hamadjida, et al.. (2025). The anti-dyskinetic effect of the clinic-ready mGluR2 positive allosteric modulator AZD8529 in the 6-OHDA-lesioned rat. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(7). 8681–8693.
3.
Ullah, Irfan, Ivan Scandale, Gabrielle Gendron‐Lepage, et al.. (2024). Bioluminescence imaging reveals enhanced SARS-CoV-2 clearance in mice with combinatorial regimens. iScience. 27(3). 109049–109049. 6 indexed citations
4.
Nuara, Stephen G., Dominique Bédard, Imane Frouni, et al.. (2023). The mGluR2/3 orthosteric agonist LY-404,039 reduces dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset. Naunyn-Schmiedeberg s Archives of Pharmacology. 396(10). 2347–2355. 5 indexed citations
5.
Richard, Jonathan, Jérémie Prévost, Catherine Bourassa, et al.. (2023). Temsavir blocks the immunomodulatory activities of HIV-1 soluble gp120. Cell chemical biology. 30(5). 540–552.e6. 12 indexed citations
6.
Frouni, Imane, Dominique Bédard, Adjia Hamadjida, et al.. (2023). Pharmacokinetic profile of bitopertin, a selective GlyT1 inhibitor, in the rat. Naunyn-Schmiedeberg s Archives of Pharmacology. 396(5). 1053–1060. 1 indexed citations
7.
Tournoux, François, et al.. (2021). Novel O-[11C]-methylated derivatives of the neprilysin inhibitor sacubitril: Radiosynthesis, autoradiography and plasma stability evaluation. Nuclear Medicine and Biology. 102-103. 34–44. 1 indexed citations
8.
Hamadjida, Adjia, Stephen G. Nuara, Dominique Bédard, et al.. (2020). Selective metabotropic glutamate receptor 2 positive allosteric modulation alleviates L-DOPA-induced psychosis-like behaviours and dyskinesia in the MPTP-lesioned marmoset. European Journal of Pharmacology. 873. 172957–172957. 25 indexed citations
9.
Kwan, Cynthia, Stephen G. Nuara, Dominique Bédard, et al.. (2020). Selective blockade of the 5-HT3 receptor acutely alleviates dyskinesia and psychosis in the parkinsonian marmoset. Neuropharmacology. 182. 108386–108386. 13 indexed citations
10.
Barama, Azemi, et al.. (2019). Development and validation of an absolute protein assay for the simultaneous quantification of fourteen CYP450s in human microsomes by HPLC-MS/MS-based targeted proteomics. Journal of Pharmaceutical and Biomedical Analysis. 173. 96–107. 13 indexed citations
11.
Gaudette, Fleur, Dominique Bédard, Cynthia Kwan, et al.. (2019). Highly sensitive HPLC-MS/MS assay for the quantitation of ondansetron in rat plasma and rat brain tissue homogenate following administration of a very low subcutaneous dose. Journal of Pharmaceutical and Biomedical Analysis. 175. 112766–112766. 10 indexed citations
12.
Frouni, Imane, Adjia Hamadjida, Cynthia Kwan, et al.. (2019). Activation of mGlu2/3 receptors, a novel therapeutic approach to alleviate dyskinesia and psychosis in experimental parkinsonism. Neuropharmacology. 158. 107725–107725. 34 indexed citations
13.
Frouni, Imane, Cynthia Kwan, Dominique Bédard, et al.. (2018). Effect of the selective 5-HT2A receptor antagonist EMD-281,014 on l-DOPA-induced abnormal involuntary movements in the 6-OHDA-lesioned rat. Experimental Brain Research. 237(1). 29–36. 18 indexed citations
14.
Gaudette, Fleur, Adjia Hamadjida, Dominique Bédard, et al.. (2018). Development of a selective and sensitive high-performance liquid chromatography-tandem mass spectrometry assay to support pharmacokinetic studies of LY-487,379 in rat and marmoset. Journal of Chromatography B. 1093-1094. 1–7. 17 indexed citations
15.
16.
Gaudette, Fleur, Adjia Hamadjida, Dominique Bédard, et al.. (2017). Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method to quantify LY‐354,740 in rat and marmoset plasma. Journal of Chromatography B. 1061-1062. 392–398. 14 indexed citations
17.
Gaudette, Fleur, et al.. (2016). Highly sensitive LC–MS/MS methods for the determination of seven human CYP450 activities using small oral doses of probe-drugs in human. Journal of Chromatography B. 1040. 144–158. 21 indexed citations
18.
Lu, Jennifer, et al.. (2015). Effects of β-Blockers and Tricyclic Antidepressants on the Activity of Human Organic Anion Transporting Polypeptide 1A2 (OATP1A2). Journal of Pharmacology and Experimental Therapeutics. 352(3). 552–558. 6 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Klaus Klinder Breakdown of academic impact, for papers by Laura Iavarone Breakdown of academic impact, for papers by S. Aubrey Stoch Breakdown of academic impact, for papers by Monique Schmitt Breakdown of academic impact, for papers by Vikash Sinha Breakdown of academic impact, for papers by Leonel Torrão Breakdown of academic impact, for papers by Anna Furgała Breakdown of academic impact, for papers by S.-�. Eckern�s Breakdown of academic impact, for papers by Philipp Huguenin Breakdown of academic impact, for papers by Terese Seifert
Rankless by CCL
2026